ATOS Earnings ATOSSA THERAPEUTICS, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–14 of 14
| Q1 2026 | 2026-03-31 | -1.11 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -4.04 | 2026-03-25 | 10-K |
| Q3 2025 | 2025-09-30 | -0.18 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.12 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.78 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -3.04 | 2026-03-25 | 10-K |
| Q3 2025 | 2024-09-30 | -0.15 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.10 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.05 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -0.24 | 2025-03-25 | 10-K |
| Q3 2024 | 2023-09-30 | -0.18 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.13 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.05 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -0.21 | 2024-04-01 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.